At the second edition of Next Gen LabCon organized by ET Pharma in Hyderabad, pharma leaders highlighted the significant growth potential of India’s CDMO (contract development and manufacturing organization) sector, likening it to the transformative phase of India’s IT industry in the late eighties and early nineties. The discussions ranged from tapping global opportunities, a fast-widening scope of Gen AI in drug discovery, emerging use of digital tools and Electronic Batch Records for fool-proof quality and regulatory compliance and how green chemistry must be adopted for environment sustainability.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/f9tWILs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment